Aegerion Pharmaceuticals News
Most Popular Aegerion Pharmaceuticals Story
Aegerion compound lowers cholesterol, weight
Aegerion Pharmaceuticals announced that preliminary data indicates positive results for three separate phase II trials involving the company's lead cholesterol candidate, AEGR-733--a microsomal Read more...
Latest Headlines
- January 20, 2011
- December 15, 2008
- November 6, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
